Literature DB >> 23744295

Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis.

O Susanto1, S E Stewart, I Voskoboinik, D Brasacchio, M Hagn, S Ellis, S Asquith, K A Sedelies, P I Bird, N J Waterhouse, J A Trapani.   

Abstract

Human and mouse granzyme (Gzm)B both induce target cell apoptosis in concert with pore-forming perforin (Pfp); however the mechanisms by which other Gzms induce non-apoptotic death remain controversial and poorly characterised. We used timelapse microscopy to document, quantitatively and in real time, the death of target cells exposed to primary natural killer (NK) cells from mice deficient in key Gzms. We found that in the vast majority of cases, NK cells from wild-type mice induced classic apoptosis. However, NK cells from syngeneic Gzm B-deficient mice induced a novel form of cell death characterised by slower kinetics and a pronounced, writhing, 'worm-like' morphology. Dying cells initially contracted but did not undergo membrane blebbing, and annexin-V staining was delayed until the onset of secondary necrosis. As it is different from any cell death process previously reported, we tentatively termed this cell death 'athetosis'. Two independent lines of evidence showed this alternate form of death was due to Gzm A: first, cell death was revealed in the absence of Gzm B, but was completely lost when the NK cells were deficient in both Gzm A and B; second, the athetotic morphology was precisely reproduced when recombinant mouse Gzm A was delivered by an otherwise innocuous dose of recombinant Pfp. Gzm A-mediated athetosis did not require caspase activation, early mitochondrial disruption or generation of reactive oxygen species, but did require an intact actin cytoskeleton and was abolished by latrunculin B and mycalolide B. This work defines an authentic role for mouse Gzm A in granule-induced cell death by cytotoxic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23744295      PMCID: PMC3741499          DOI: 10.1038/cdd.2013.59

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  44 in total

1.  Is the centriole bound to the nuclear membrane?

Authors:  M Bornens
Journal:  Nature       Date:  1977-11-03       Impact factor: 49.962

2.  Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.

Authors:  Jamie A Lopez; Olivia Susanto; Misty R Jenkins; Natalya Lukoyanova; Vivien R Sutton; Ruby H P Law; Angus Johnston; Catherina H Bird; Phillip I Bird; James C Whisstock; Joseph A Trapani; Helen R Saibil; Ilia Voskoboinik
Journal:  Blood       Date:  2013-02-01       Impact factor: 22.113

3.  Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes.

Authors:  A Müllbacher; P Waring; R Tha Hla; T Tran; S Chin; T Stehle; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks.

Authors:  P J Beresford; D Zhang; D Y Oh; Z Fan; E L Greer; M L Russo; M Jaju; J Lieberman
Journal:  J Biol Chem       Date:  2001-09-12       Impact factor: 5.157

5.  Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes.

Authors:  J A Trapani; J L Klein; P C White; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors.

Authors:  Vivien R Sutton; Michelle E Wowk; Michael Cancilla; Joseph A Trapani
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

7.  Granzyme B encoded by the commonly occurring human RAH allele retains pro-apoptotic activity.

Authors:  Jiuru Sun; Catherina H Bird; Kevin Y Thia; Antony Y Matthews; Joseph A Trapani; Phillip I Bird
Journal:  J Biol Chem       Date:  2004-01-29       Impact factor: 5.157

8.  Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A.

Authors:  Zusen Fan; Paul J Beresford; Dong Zhang; Zhan Xu; Carl D Novina; Akira Yoshida; Yves Pommier; Judy Lieberman
Journal:  Nat Immunol       Date:  2003-01-13       Impact factor: 25.606

9.  A role for the actin cytoskeleton in cell death and aging in yeast.

Authors:  Campbell W Gourlay; Lindsay N Carpp; Paul Timpson; Steven J Winder; Kathryn R Ayscough
Journal:  J Cell Biol       Date:  2004-03-15       Impact factor: 10.539

10.  The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene.

Authors:  Ilia Voskoboinik; Marie-Claude Thia; Annette De Bono; Kylie Browne; Erika Cretney; Jacob T Jackson; Phillip K Darcy; Stephen M Jane; Mark J Smyth; Joseph A Trapani
Journal:  J Exp Med       Date:  2004-09-14       Impact factor: 14.307

View more
  17 in total

1.  TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells.

Authors:  Jian Gu; Ling Lu; Maogen Chen; Lili Xu; Qin Lan; Qiang Li; Zhongmin Liu; Guihua Chen; Ping Wang; Xuehao Wang; David Brand; Nancy Olsen; Song Guo Zheng
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

Review 2.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

3.  Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A.

Authors:  Dion Kaiserman; Sarah E Stewart; Kim Plasman; Kris Gevaert; Petra Van Damme; Phillip I Bird
Journal:  J Biol Chem       Date:  2014-02-06       Impact factor: 5.157

4.  Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells.

Authors:  Alexandra C Vrazo; Adrianne E Hontz; Sarah K Figueira; Braeden L Butler; Julie M Ferrell; Brock F Binkowski; Jinzhu Li; Kimberly A Risma
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

Review 5.  Roles of cytotoxic and helper innate lymphoid cells in cancer.

Authors:  Camille Guillerey
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

6.  A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage.

Authors:  D Brasacchio; T Noori; C House; A J Brennan; K J Simpson; O Susanto; P I Bird; R W Johnstone; J A Trapani
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

Review 7.  Protease signaling in animal and plant-regulated cell death.

Authors:  Guy S Salvesen; Anne Hempel; Nuria S Coll
Journal:  FEBS J       Date:  2015-12-31       Impact factor: 5.542

8.  Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease.

Authors:  Sarvari Velaga; Sya N Ukena; Ulrike Dringenberg; Christina Alter; Julian Pardo; Olivia Kershaw; Anke Franzke
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

9.  A natural genetic variant of granzyme B confers lethality to a common viral infection.

Authors:  Christopher E Andoniou; Vivien R Sutton; Matthew E Wikstrom; Peter Fleming; Kevin Y T Thia; Antony Y Matthews; Dion Kaiserman; Iona S Schuster; Jerome D Coudert; Preethi Eldi; Geeta Chaudhri; Gunasegaran Karupiah; Phillip I Bird; Joseph A Trapani; Mariapia A Degli-Esposti
Journal:  PLoS Pathog       Date:  2014-12-11       Impact factor: 6.823

10.  Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time.

Authors:  Misty R Jenkins; Jesse A Rudd-Schmidt; Jamie A Lopez; Kelly M Ramsbottom; Stuart I Mannering; Daniel M Andrews; Ilia Voskoboinik; Joseph A Trapani
Journal:  J Exp Med       Date:  2015-03-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.